SOAT2 and hepatocellular carcinoma: Although numerous biomarkers are used for HCC prognosis prediction, this study is the first to propose a prognostic model based on six genes related to de novo lipogenesis (G6PD, LCAT, SERPINE1, SOAT2, CYP2C9, and UGT1A10).